Tricuspid regurgitation: recent advances in understanding pathophysiology, severity grading and outcome

RT Hahn, LP Badano, PE Bartko… - European Heart …, 2022 - academic.oup.com
Heightened interest in tricuspid regurgitation (TR) stems from the consistent association of
mortality with greater severity of TR, and a low use of surgical solutions in the setting of high …

Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with …

WA Zoghbi, D Adams, RO Bonow… - Journal of the American …, 2017 - Elsevier
ASE has gone green! Visit www. aseuniversity. org to earn free continuing medical
education credit through an online activity related to this article. Certificates are available for …

2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint …

Writing Committee Members, CM Otto… - Journal of the American …, 2021 - jacc.org
The recommendations listed in this document are, whenever possible, evidence based. An
extensive review was conducted on literature published through March 1, 2020. Searches …

2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American …

CM Otto, RA Nishimura, RO Bonow… - Journal of the American …, 2021 - jacc.org
Aim This executive summary of the valvular heart disease guideline provides
recommendations for clinicians to diagnose and manage valvular heart disease as well as …

[HTML][HTML] Percutaneous repair or medical treatment for secondary mitral regurgitation

JF Obadia, D Messika-Zeitoun, G Leurent… - … England Journal of …, 2018 - Mass Medical Soc
Background In patients who have chronic heart failure with reduced left ventricular ejection
fraction, severe secondary mitral-valve regurgitation is associated with a poor prognosis …

[PDF][PDF] 2017 ESC/EACTS Guidelines for the management of valvular heart disease

H Baumgartner, V Falk, JJ Bax… - Polish Heart …, 2018 - journals.viamedica.pl
Recenzenci dokumentu: Marco Roffi, koordynator recenzji ze strony CPG (Szwajcaria),
Ottavio Alfieri1, koordynator recenzji ze strony EACTS (Włochy), Stefan Agewall (Norwegia) …

Клинические рекомендации ОССН-РКО-РНМОТ. Сердечная недостаточность: хроническая (ХСН) и острая декомпенсированная (ОДСН). Диагностика …

ВЮ Мареев, ИВ Фомин, ФТ Агеев, ЮЛ Беграмбекова… - Кардиология, 2018 - lib.ossn.ru
1–«МНОЦ МГУ им. МВ Ломоносова», 119192, Москва, Ломоносовский пр-кт, д. 27, корп.
10 2–ФГБОУ ВО «ПИМУ» МЗ РФ, 603950, Нижний Новгород, пл. Минина и Пожарского …

JCS/JSCS/JATS/JSVS 2020 guidelines on the management of valvular heart disease

C Izumi, K Eishi, K Ashihara, T Arita, Y Otsuji… - Circulation …, 2020 - jstage.jst.go.jp
The “Guidelines on the Management of Valvular Heart Disease” were initially published as
the “Guidelines on Non-pharmacological Treatment of Valvular Heart Disease” in 2002 …

Feasibility study of the transcatheter valve repair system for severe tricuspid regurgitation

S Kodali, RT Hahn, MF Eleid, R Kipperman… - Journal of the American …, 2021 - jacc.org
Background Tricuspid regurgitation (TR) is a prevalent disease with limited treatment
options. Objectives This is the first 30-day report of the US single-arm, multicenter …

Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial

L Lagae, J Sullivan, K Knupp, L Laux, T Polster… - The Lancet, 2019 - thelancet.com
Background Dravet syndrome is a rare, treatment-resistant developmental epileptic
encephalopathy characterised by multiple types of frequent, disabling seizures …